{"id":"W2027176779","doi":"10.1038/bjc.2011.201","title":"XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":227,"is_retracted":false,"has_abstract":true,"ca_institutions":"CancerCare Manitoba; St. Boniface Hospital","funders":"","keywords":"Folinic acid; Oxaliplatin; Medicine; Bevacizumab; Capecitabine; Internal medicine; FOLFOX; Colorectal cancer; Population; Placebo; Hazard ratio; Fluorouracil; Oncology; Neutropenia; Gastroenterology; Surgery; Chemotherapy; Cancer; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002753498,0.0002235845,0.0007540121,0.0001021571,0.0001980265,0.00003840382,0.0001407076,0.00006483773,0.0008632574],"category_scores_gemma":[0.0001333877,0.0001911734,0.000324712,0.0002192197,0.000107616,0.0001598613,0.00002646405,0.0002270516,0.000003776111],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003200904,"about_ca_system_score_gemma":0.0005421924,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005094838,"about_ca_topic_score_gemma":0.009926096,"domain_scores_codex":[0.9982457,0.00003456946,0.0007171286,0.0002545245,0.00038239,0.0003656815],"domain_scores_gemma":[0.998249,0.0000839099,0.0005156252,0.0001045586,0.0008411428,0.0002057755],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.07731897,0.001668047,0.01674323,0.0001664207,0.006369534,0.002100271,0.00300612,0.00003546742,0.0007106083,0.00003993864,0.06865785,0.8231835],"study_design_scores_gemma":[0.06036042,0.01949528,0.3954279,0.002206307,0.002356562,0.00349205,0.0005017766,0.00009566661,0.02576689,0.001062411,0.4884632,0.000771508],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9327781,0.06006806,0.0000510376,0.002281185,0.001064217,0.0008811821,0.0005280992,0.00002924444,0.002318853],"genre_scores_gemma":[0.9333563,0.06278714,0.0008947433,0.0008363639,0.0005948514,0.0002362091,0.00002243101,0.00004634591,0.001225653],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.822412,"threshold_uncertainty_score":0.9452063,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04379543442494756,"score_gpt":0.3317247483501661,"score_spread":0.2879293139252185,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}